▲ Lee Hae-jin, global investment officer at Naver
In the process of establishing a joint venture between Naver and Daewoong Pharmaceutical, the Fair Trade Commission has determined that it is not subject to the regulation of private gain.
Previously, Kim Jong-min, a member of the Democratic Party of Korea, questioned during a parliamentary audit that Global Investment Manager Lee Hae-jin "didn't he cheat on private interests in a deformed form?" Regulating it as a transaction needs to be prudent at this point.”
The Fair Trade Commission replied, "Daewoong, which Jieum invested in, is not an affiliate in which Lee Hae-jin and his relatives own more than 20 percent of the shares, so it does not meet the requirements for support objects and is not subject to the regulation of private gain."
In addition, 'Dana Data', a joint venture between Naver and Daewoong Pharmaceutical, explained that there is no transaction itself for sales activities since its establishment, so "there is no practical benefit to review whether or not there is unfair support."
However, the Fair Trade Commission added, "We will continue to monitor whether transactions with Naver and others will be made in the future."
(Photo = National Assembly photographers, Yonhap News)